Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Colombian ICU data may unlock secrets of severe dengue

NCT ID NCT05938647

Knowledge-focused Sponsor: Hospital Departamental de Villavicencio Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study reviewed the medical records of 199 patients with severe dengue who were treated in intensive care units in Villavicencio, Colombia. Researchers looked at patient details, lab results, and outcomes to better understand the disease in a real-world ICU setting. No new treatments were tested; the goal was to gather information that could improve future care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
This study could help doctors better understand severe dengue in intensive care, potentially leading to improved treatment guidelines for ICU patients.
What could go wrong
This is a small, retrospective, single-region study that only looks at past records. It cannot prove what treatments work best, only describe what happened.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

199 people

The number who actually took part.

Started

Jul 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The participants in the trial are those patients treated in a critical care unit for dengue during the period of study, according to the registers of admission in the institution.

Ages

Up to 120 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients admitted at a critical care unit with a diagnose of dengue either clinical or by a positive serology or molecular diagnostic methods. Exclusion Criteria: * Patients with a post admission diagnosis different than dengue either clinical or by a negative serology.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Severe dengue are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dengue disease Dengue hemorrhagic fever dengue shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Severe dengue

Contacts and locations

Locations

  • Clinica Primavera

    Villavicencio, Meta Department, 50001, Colombia

  • Hospital Departamental de Villavicencio

    Villavicencio, Meta Department, 50001, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.